RVTY

#730
Revvity, Inc. Common Stock
104.5 2 USD
+2.09%
부문: 헬스케어
베이스: USD
수익 통화: USD
일일 변동 비율
103.50
105.04
년간 변동
81.22
118.26
일일 변동
+2.09%
월간 변동
+25.95%
6달 변화
+1.88%
년간 변동율
+10.18%
이전 종가
102.3 8
Open
103.5 4
저가
103.5 0
High
105.0 4
양
1 766
전체 차트 열기 Full chart

Financials

개요 성명 통계 배당금
4분기 연간
  • Market Capitalization 11.66 B
  • Employee 11 K
  • Founded N/A
  • CEO Prahlad Singh
  • Website www.revvity.com
  • Headquarter Massachusetts, United States
  • FIGI BBG000FXW512
  • Industry 분석 & 리서치
총매출
순이익
주당 순이익(기본 EPS)
총부채
잉여 현금 흐름
현금 및 현금성 자산
주가수익비율
46.91
주가매출액비율
3.96
주당 배당금
0.28
배당수익률 %
0.29

Revvity, Inc. Common Stock

Revvity, Inc. is an American company in the life sciences and diagnostics business that is focused on selling to the pharmaceutical and biotechnology industries, especially in relation to approaches making use of new cell therapy or gene therapy developments. Its origins lie with the long-existing company PerkinElmer, which has been in a variety of business lines. In 2022, a split of PerkinElmer resulted in one part, comprising its applied, food and enterprise services businesses, being sold to the private equity firm New Mountain Capital for $2.45 billion and thus no longer being public but keeping the PerkinElmer name. The other part, comprising the life sciences and diagnostics businesses, remained public but required a new name, which in 2023 was announced as Revvity, Inc. From the perspective of Revvity, the goal of creating a separate company was that its businesses might show greater profit margins and more in the way of growth potential. An associated goal was to have more financial flexibility moving forward. On May 16, 2023, the PerkinElmer stock symbol PKI was replaced by the new symbol RVTY.

뉴스